ArticleFrontiers in neuroscience2025
Toward accurate Alzheimer's detection: transfer learning with ResNet50 for MRI-based diagnosis.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alzheimer's disease (AD), the most prevalent form of dementia, affects more than 50 million individuals worldwide and demands accurate and timely diagnosis to improve patient outcomes. Traditional machine-learning approaches for AD detection using MRI often rely on manual feature extraction, which is labor-intensive and limits scalability. There is a growing need for automated, high-accuracy methods that can support clinical workflows and respond to the expected tripling of AD cases by 2050. Methods: This study proposes an automated feature-extraction approach using a pre-trained ResNet50 convolutional neural network (CNN) applied to brain MRI scans. Extracted deep features were classified using three different algorithms: Softmax, Support Vector Machine (SVM), and Random Forest (RF). Performance was evaluated on two benchmark datasets: ADNI and MIRIAD. Results: Among the tested models, the ResNet50-Softmax combination demonstrated the highest performance, surpassing state-of-the-art benchmarks (85.7%-98.59%). It achieved 99% sensitivity, 98% specificity, and an overall 99% accuracy on the ADNI dataset. On the MIRIAD dataset, the model also performed strongly, reaching 96% accuracy. Discussion: The results confirm that transfer learning using ResNet50 significantly enhances the accuracy and scalability of AD diagnosis from MRI data. By eliminating the need for manual feature extraction and offering near-perfect classification performance, this approach can streamline clinical neuroimaging workflows. These findings highlight the potential of deep learning models to support early diagnosis and meet the increasing global burden of Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.